Genetic polymorphism of coagulation factors as a cardiovascular risk factor
Iacoviello, L.; Donati, M.B.
Minerva Cardioangiologica 47(11): 401-402
1999
ISSN/ISBN: 0026-4725 PMID: 10641411 Document Number: 504646
Document emailed within 1 workday
Related Documents
Guerra, A.; Rego, C.; Castro, E.M.; Sinde, S.; Silva, D.; Rodrigues, P.; Crespo, M.E.; Albergaria, F.; Bicho, M. 2000: Acid phosphatase, genetic polymorphism and cardiovascular risk factors in a pediatric population Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 19(6): 679-691Smith, M.A.C.; Silva, M.D.A.; Cendoroglo, M.S.; Ramos, L.R.; Araujo, L.M.Q.; Labio, R.W.; Burbano, R.R.; Chen, E.S.; Payão, S.L.M. 2007: TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population Brazilian Journal of Medical and Biological Research 40(11): 1465-1472
Salagovic, J.; Kalina, I.; Stubna, J.; Habalová, V.; Hrivnák, M.; Valanský, L.; Kohút, A.; Biros, E. 1998: Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers Neoplasma 45(5): 312-317
Teren, A.; Gavorník, P. 2007: Genetic factors and the risk of cardiovascular diseases Vnitrni Lekarstvi 53(6): 678-693
Jin, Y.H.; Shen, X.L.; Wang, M.S.; Xu, X.M.; Liu, M.N.; Zhao, Z.S.; Zheng, J.Y. 2016: Association between the C46T polymorphism of coagulation factor Ⅻ gene and the involvement of factor Ⅻ activity in patients with unexplained recurrent spontaneous abortion Zhonghua Fu Chan Ke Za Zhi 51(8): 597-601
Seremak-Mrozikiewicz, A.; Drews, K.; Kurzawińska, G.; Barlik, M.; Mrozikiewicz, P.ła.M. 2009: The connection between Arg353Gln polymorphism of coagulation factor VIi and recurrent miscarriages Ginekologia Polska 80(1): 8-13
Wartiovaara, U.; Mikkola, H.; Szôke, G.; Haramura, G.; Kárpáti, L.; Balogh, I.; Lassila, R.; Muszbek, L.; Palotie, A. 2000: Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A Thrombosis and Haemostasis 84(4): 595-600
Vrhovski, D.; Mestrić, Z.; Subić, N.; Surina, B.; Kranjcević, S. 1985: Established risk factors and complementary risk factors as additional parameters in evaluating the risk of cardiovascular diseases Lijecnicki Vjesnik 107(11-12): 481-484
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Gafarov, V.V.; Voevoda, M.I.; Gromova, E.A.; Maksimov, V.N.; Gagulin, I.V.; Iudin, N.S.; Gafarova, A.V.; Mishakova, T.M. 2013: Genetic markers for trait anxiety as one of the risk factors for cardiovascular diseases (WHO-MONICA program, MONICA-psychosocial subprogram) Terapevticheskii Arkhiv 85(4): 47-51
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Horai, S. 1976: Genetic polymorphism of human serum factor B (Bf) in Japanese Jinrui Idengaku Zasshi. Japanese Journal of Human Genetics 21(3): 177-186
Dobrynina, L.A.; Kalashnikova, L.A.; Patrusheva, N.L.; Kovalenko, T.F.; Patrushev, L.I. 2012: Polymorphism of 5,10-methylenetetrahydropholate reductase, prothrombin, and coagulation factor V genes in young patients with ischemic stroke Klinicheskaia Meditsina 90(3): 37-40
Bertina, R.M. 1997: Factor V Leiden and other coagulation factor mutations affecting thrombotic risk Clinical Chemistry 43(9): 1678-1683
Kamphuisen, P.W.; Eikenboom, H.C.; Rosendaal, F.R.; Bertina, R.M. 2001: High concentration of coagulation factor VIIi as a risk factor for thrombosis Nederlands Tijdschrift Voor Geneeskunde 145(46): 2213-2217
Lutz, W.; Tarkowski, M.; Nowakowska, E. 2001: Genetic polymorphism of glutathione s-transferase as a factor predisposing to allergic dermatitis Medycyna Pracy 52(1): 45-51
London, S.J.; Lehman, T.A.; Taylor, J.A. 1997: Myeloperoxidase genetic polymorphism and lung cancer risk Cancer Research 57(22): 5001-5003
Li, Z.; Li, H-quan.; Yan, Y.; Liu, Y.; Hao, W.; Niu, J-qin.; Yin, J-Ming.; Li, H. 2007: Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients Zhonghua Yi Xue Za Zhi 87(30): 2105-2108
Lv, L.; Zou, H.-j.; Lin, G.-w.; Irons, R.R. 2005: Genetic polymorphism of tumor necrosis factor-alpha in patients with chronic benzene poisoning Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 23(3): 195-198